The Pennsylvania Department of Health (DOH) issued a Health Advisory to report Serious Adverse Events After Ceftriaxone Administration. The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments, is investigating reports of serious adverse events, including deaths, following receipt of injectable ceftriaxone. To date, events have not been associated with a single product manufacturer or lot, and a definitive causal link to ceftriaxone has not been established. DOH is requesting reports of serious adverse events following the administration of ceftriaxone to assist with the ongoing investigation. If you have any questions, or to report cases, please call your local health department or contact DOH at 877-PA-HEALTH (877-724-3528).
